Related Experiment Video

Updated: Aug 8, 2026

Novel Atomic Force Microscopy Based Biopanning for Isolation of Morphology Specific Reagents against TDP-43 Variants in Amyotrophic Lateral Sclerosis
13:31

Novel Atomic Force Microscopy Based Biopanning for Isolation of Morphology Specific Reagents against TDP-43 Variants in Amyotrophic Lateral Sclerosis

Published on: February 12, 2015

Alpha-interferon therapy in a case of probable progressive multifocal leukoencephalopathy

C Colosimo1, P Lebon, M Martelli

  • 1International Medical Service, Roma, Italy.

Acta Neurologica Belgica
|January 1, 1992
PubMed

Insights

This study reports a probable case of progressive multifocal leukoencephalopathy (PML) in a patient with non-Hodgkin's lymphoma. Treatment with alpha-interferon led to significant neurological and MRI improvement.

Area of Science:

  • Neurology
  • Oncology
  • Immunology

Background:

  • Progressive multifocal leukoencephalopathy (PML) is a rare, often fatal, demyelinating disease of the central nervous system.
  • PML is caused by the JC virus, typically occurring in immunocompromised individuals.
  • The patient had a history of non-Hodgkin's lymphoma in complete remission.

Observation:

  • A 63-year-old male presented with clinical and magnetic resonance imaging (MRI) findings suggestive of probable PML.
  • The patient's neurological status and MRI scans were monitored.
  • Neurological deficits included aphasia and motor impairment.

Findings:

  • Introduction of intramuscular alpha-interferon therapy was followed by marked improvement.
  • Neurological recovery included significant improvement in aphasia and motor function.
  • MRI findings also demonstrated a clear positive response to treatment.

Implications:

  • Alpha-interferon may represent a potential therapeutic option for progressive multifocal leukoencephalopathy.
  • This case highlights the possibility of recovery from PML with specific treatments.
  • Further research into interferon-based therapies for PML is warranted.

More Related Videos

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein14:45

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein

Published on: July 29, 2022

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

Related Concept Videos

Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...